Chief Physician | Zhejiang University | China
Dr. Ai-Xia Liu is a prominent reproductive endocrinologist and Chief Physician at the Women’s Hospital, School of Medicine, Zhejiang University, China. With a Ph.D. in Reproductive Endocrinology from Zhejiang University and an M.D. from Sichuan University, Dr. Liu has developed a strong academic and clinical foundation in reproductive medicine. Her primary research expertise encompasses reproductive mechanisms, infertility, early pregnancy loss, decidual cell biology, placental physiology, and the molecular regulation of reproductive disorders, with a particular focus on the ubiquitin-proteasome pathway, endoplasmic reticulum stress, and metabolic regulation during pregnancy. Over the past two decades, Dr. Liu has authored 44 peer-reviewed publications with over 1,060 citations and an h-index of 18, reflecting her sustained scholarly impact in reproductive science. Her work has been published in high-impact journals such as Frontiers in Immunology, iScience, International Journal of Molecular Sciences, and Cell Death & Disease. Dr. Liu’s research is internationally collaborative, including academic exchanges with the University of Wisconsin (USA) and the University of British Columbia (Canada). She has successfully led several national and provincial grants, including projects funded by the National Key R&D Program of China and the National Natural Science Foundation of China, advancing understanding of endometrial decidualization, early pregnancy loss, and maternal-fetal interactions. As an active member of multiple professional societies, Dr. Liu contributes to the advancement of clinical reproductive health standards. Her ongoing work aims to translate molecular insights into diagnostic and therapeutic innovations, promoting women’s reproductive health and addressing global challenges in fertility and early pregnancy management.
Profiles: Scopus | ORCID
Featured Publications
-
Liu, A., Chen, X., Zhou, Y., Wang, D., & Zhang, M. (2025). Transcriptomic analysis reveals the landscape of the shared gene network between ectopic pregnancy and early pregnancy loss. Genes and Diseases.
-
Liu, A., Jin, M., He, W., & Wang, D. (2025). TET3 inhibits the decidualization of human endometrial stromal cells by regulating ITGA10 transcription through recruiting HDAC1/2. Archives of Biochemistry and Biophysics.
-
Liu, A., Zhou, Y., Chen, X., & Wang, D. (2025). Outcomes of Assisted Reproductive Technology in Women With Hepatitis B Infection. Journal of Viral Hepatitis.
-
Liu, A., Jing, M., Xie, L., & Wang, D. (2025). The transcription factor XBP1 regulates mitochondrial remodel and autophagy in spontaneous abortion. International Immunopharmacology. (1 citation)
Dr. Ai-Xia Liu’s pioneering research in reproductive endocrinology integrates molecular biology and clinical science to address global challenges in infertility, early pregnancy loss, and maternal-fetal health. Her work advances scientific understanding of reproductive mechanisms and supports innovations in diagnostic and therapeutic strategies, contributing significantly to improving women’s health and reproductive outcomes worldwide.
